Feasibility of FDG Imaging of the Coronary Arteries Comparison Between Acute Coronary Syndrome and Stable Angina

被引:219
|
作者
Rogers, Ian S.
Nasir, Khurram
Figueroa, Amparo L.
Cury, Ricardo C.
Hoffmann, Udo
Vermylen, David A.
Brady, Thomas J.
Tawakol, Ahmed [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiac MR PET CT Program,Div Cardiol, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
18-fluorodeoxyglucose positron emission tomography; cardiac computed tomography; aorta; coronary arteries; inflammation; POSITRON-EMISSION-TOMOGRAPHY; ATHEROSCLEROTIC PLAQUE INFLAMMATION; HIGH-FAT; LOW-CARBOHYDRATE; F-18-FDG UPTAKE; PET; DISEASE; SUPPRESSION; PROGRESSION; PROVIDES;
D O I
10.1016/j.jcmg.2010.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study tested the hypothesis that fluorodeoxyglucose (FDG) uptake within the ascending aorta and left main coronary artery (LM), measured using positron emission tomography (PET), is greater in patients with recent acute coronary syndrome (ACS) than in patients with stable angina. BACKGROUND Inflammation is known to play an important role in atherosclerosis. Positron emission tomography imaging with F-18-FDG provides a measure of plaque inflammation. METHODS Twenty-five patients (mean age 57.9 +/- 9.8 years, 72% male, 10 ACS, and 15 stable angina) underwent cardiac computed tomographic angiography and PET imaging with F-18-FDG after invasive angiography. Images were coregistered, and FDG uptake was measured at locations of interest for calculation of target-to-background ratios (TBR). Additionally, FDG uptake was measured at the site of the lesion deemed clinically responsible for the presenting syndrome (culprit) by virtue of locating the stent deployed to treat the syndrome. RESULTS The FDG uptake was higher in the ACS versus the stable angina groups in the ascending aorta (median [interquartile ranges] TBR 3.30 [2.69 to 4.12] vs. 2.43 [2.00 to 2.86], p = 0.02), as well as the LM (2.48 [2.30 to 2.93] vs. 2.00 [1.71 to 2.44], p = 0.03, respectively). The TBR was greater for culprit lesions associated with ACS than for lesions stented for stable coronary syndromes (2.61 vs. 1.74, p = 0.02). Furthermore, the TBR in the stented lesions (in ACS and stable angina groups) correlated with C-reactive protein (r = 0.58, p = 0.04). CONCLUSIONS This study shows that in patients with recent ACS, FDG accumulation is increased both within the culprit lesion as well as in the ascending aorta and LM. This observation suggests inflammatory activity within atherosclerotic plaques in acute coronary syndromes and supports intensification of efforts to refine PET methods for molecular imaging of coronary plaques. (J Am Coll Cardiol Img 2010;3:388-97) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:388 / 397
页数:10
相关论文
共 50 条
  • [21] The change of serum serotonin levels between acute coronary syndrome and chronic stable angina undergoing percutaneous coronary intervention
    Han, D.
    Shin, D. G.
    Kang, M. K.
    Choi, S.
    Lee, N.
    Cho, J. R.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1542 - 1542
  • [22] Comparison of Archival Angiographic Findings in Patients Later Developing Acute Coronary Syndrome or Stable Angina
    Yamaya, Shohei
    Morino, Yoshihiro
    Taguchi, Yuya
    Ninomiya, Ryo
    Ishida, Masaru
    Fusazaki, Tetsuya
    Itoh, Tomonori
    Kimura, Takumi
    INTERNATIONAL HEART JOURNAL, 2020, 61 (03) : 454 - 462
  • [23] LYMPHOCYTE SUBPOPULATIONS IN LYMPH NODES AND PERIPHERAL BLOOD. A COMPARISON BETWEEN PATIENTS WITH STABLE ANGINA AND ACUTE CORONARY SYNDROME
    Backteman, K.
    Ernerudh, J.
    Jonasson, L.
    INFLAMMATION RESEARCH, 2011, 60 : 215 - 216
  • [24] Plaque ruptures in stable angina pectoris compared with acute coronary syndrome
    Hong, Myeong-Ki
    Mintz, Gary S.
    Lee, Cheol Whan
    Park, Kyoung-Min
    Lee, Bong-Ki
    Kim, Young-Hak
    Kang, Duk-Hyun
    Cheong, Sang-Sig
    Song, Jae-Kwan
    Kim, Jae-Joong
    Park, Seong-Wook
    Park, Seung-Jung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 114 (01) : 78 - 82
  • [25] Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina
    Gil, M
    Zarebinski, M
    Adamus, J
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 83 (01) : 43 - 46
  • [26] Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris
    Qingwei Ji
    Yingzhong Lin
    Zhishan Liang
    Kunwu Yu
    Yuyang Liu
    Zhe Fang
    Ling Liu
    Ying Shi
    Qiutang Zeng
    Chao Chang
    Meng Chai
    Yujie Zhou
    Cardiovascular Diabetology, 13
  • [27] Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina
    Biasucci, Luigi Marzio
    Porto, Italo
    Di Vito, Luca
    De Maria, Giovanni Luigi
    Leone, Antonio Maria
    Tinelli, Giovanni
    Tritarelli, Alessandra
    Di Rocco, Giuliana
    Snider, Francesco
    Capogrossi, Maurizio C.
    Crea, Filippo
    CIRCULATION JOURNAL, 2012, 76 (09) : 2174 - 2182
  • [28] Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris
    Ji, Qingwei
    Lin, Yingzhong
    Liang, Zhishan
    Yu, Kunwu
    Liu, Yuyang
    Fang, Zhe
    Liu, Ling
    Shi, Ying
    Zeng, Qiutang
    Chang, Chao
    Chai, Meng
    Zhou, Yujie
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [29] Differences in plaque composition of the target lesion between acute coronary syndrome and stable angina pectoris
    Nasu, K
    Tsuchikane, E
    Kato, O
    Surmely, JF
    Fujita, H
    Takeda, Y
    Itoh, T
    Ehara, M
    Kinoshita, Y
    Terashima, M
    Matsubara, T
    Suzuki, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 49B - 49B
  • [30] Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris.
    Qiao X.Z.
    Yang Y.M.
    Xu Z.R.
    Yang L.A.
    Journal of Zhejiang University SCIENCE B, 2007, 8 (12): : 875 - 880